Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sagar Lonial

Showing results (81-90 of 440) with videos related to

Pageof 44
Sort By:
The New England Journal of Medicine|May 4, 2017
Academic, Foundation, and Industry Collaboration in Finding New TherapiesBonnie W Ramsey, Gerald T Nepom, Sagar Lonial
Cancer|August 10, 2021
"I took the road less traveled, and that has made all the difference": Making a case for high-dose therapy and autologous stem cell transplantation in elderly patients with newly diagnosed multiple myelomaAjay K Nooka, Nisha S Joseph, Sagar Lonial
Clinical Lymphoma & Myeloma|November 21, 2007
Maintenance therapy in lymphomaRonald Mihelic, Jonathan Kaufman, Sagar Lonial, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2011
Treatment options for relapsed and refractory multiple myelomaSagar Lonial, Constantine S Mitsiades, Paul G Richardson
The Lancet. Haematology|February 3, 2022
Risk stratified management approaches for smouldering multiple myeloma: clinical research becomes clinical practiceSagar Lonial, S Vincent Rajkumar, Maria Victoria Mateos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2023
Glücksklee, the Quad, and High-Risk MyelomaAjay K Nooka, Jonathan L Kaufman, Sagar Lonial
Biologics : Targets & Therapy|February 7, 2013
Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomibAjay Nooka, Charise Gleason, Daniela Casbourne, et al.
Clinical Advances in Hematology & Oncology : H&O|May 5, 2023
Novel approaches to the treatment of multiple myelomaKathryn T Maples, Sara A Scott, Sagar Lonial
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2020
Reply to N. Biran et alSagar Lonial, Madhav V Dhodapkar, S Vincent Rajkumar
Expert Opinion on Biological Therapy|October 25, 2013
Elotuzumab: a novel anti-CS1 monoclonal antibody for the treatment of multiple myelomaSagar Lonial, Jonathan Kaufman, Jacob Laubach, et al.
Pageof 44

Showing results (81-90 of 440) with videos related to

Sort By:
Pageof 44
The New England Journal of Medicine|May 4, 2017
Academic, Foundation, and Industry Collaboration in Finding New TherapiesBonnie W Ramsey, Gerald T Nepom, Sagar Lonial
Cancer|August 10, 2021
"I took the road less traveled, and that has made all the difference": Making a case for high-dose therapy and autologous stem cell transplantation in elderly patients with newly diagnosed multiple myelomaAjay K Nooka, Nisha S Joseph, Sagar Lonial
Clinical Lymphoma & Myeloma|November 21, 2007
Maintenance therapy in lymphomaRonald Mihelic, Jonathan Kaufman, Sagar Lonial, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2011
Treatment options for relapsed and refractory multiple myelomaSagar Lonial, Constantine S Mitsiades, Paul G Richardson
The Lancet. Haematology|February 3, 2022
Risk stratified management approaches for smouldering multiple myeloma: clinical research becomes clinical practiceSagar Lonial, S Vincent Rajkumar, Maria Victoria Mateos
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2023
Glücksklee, the Quad, and High-Risk MyelomaAjay K Nooka, Jonathan L Kaufman, Sagar Lonial
Biologics : Targets & Therapy|February 7, 2013
Relapsed and refractory lymphoid neoplasms and multiple myeloma with a focus on carfilzomibAjay Nooka, Charise Gleason, Daniela Casbourne, et al.
Clinical Advances in Hematology & Oncology : H&O|May 5, 2023
Novel approaches to the treatment of multiple myelomaKathryn T Maples, Sara A Scott, Sagar Lonial
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2020
Reply to N. Biran et alSagar Lonial, Madhav V Dhodapkar, S Vincent Rajkumar
Expert Opinion on Biological Therapy|October 25, 2013
Elotuzumab: a novel anti-CS1 monoclonal antibody for the treatment of multiple myelomaSagar Lonial, Jonathan Kaufman, Jacob Laubach, et al.
Pageof 44